Comprehensive Genomic Profiling for Precision Oncology: Analytical Validation and Clinical Utility in Solid Tumors
Diagnostics · 03.04.2026 · 16 (7) · 1087
DOI: 10.3390/diagnostics16071087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 03.04.2026. Verfasst von Ashis K Mondal und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Comprehensive genomic profiling (CGP) is increasingly used in precision oncology to identify actionable genomic alterations and guide targeted therapies in solid tumors. However, the clinical implementation of CGP assays requires rigorous analytical validation to ensure accurate and reproducible detection of diverse genomic alterations across heterogeneous tumor samples. Despite rapid advancements in next-generation sequencing technologies, there remains a need for validated CGP platforms that demonstrate reliable performance and readiness for routine clinical use.
Methods
This study evaluated the analytical and clinical performance of a CGP assay capable of detecting multiple genomic alteration types, including single nucleotide variants (SNVs), insertions/deletions (Indels), copy number variations (CNVs), gene fusions, and tumor mutational burden (TMB). Validation was conducted using patient-derived 117 FFPE tumor samples, external proficiency testing materials, and reference standards. Assay performance was assessed through comparison with orthogonal methods and through evaluation of reproducibility, limit of detection, and TMB concordance.
Results
The assay demonstrated excellent analytical performance, achieving 100% sensitivity, specificity, and accuracy for variant detection across evaluated samples. Strong concordance was observed for TMB estimation (R2 = 0.9925), with consistent classification of TMB-high cases. The assay showed robust inter- and intra-run reproducibility and reliable detection of low-frequency variants. Limit-of-detection (LOD) analysis confirmed accurate SNV detection at approximately 1% variant allele frequency and reliable RNA fusion detection at low input levels.
Conclusions
The validated CGP assay provides accurate, reproducible, and comprehensive detection of clinically relevant genomic alterations in solid tumors. These results support its suitability for routine clinical deployment, enabling reliable genomic profiling to inform precision oncology treatment decisions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
- Greenwood Genetic Center, Greenwood, SC 29646, USA.
- Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30307, USA.
ORCID-Profile: Ashis K Mondal, Pankaj Kumar Ahluwalia, Jaspreet Farmaha, Ravindra Kolhe
Zitieren
APA
Mondal, A. K., Vashisht, A., Vashisht, V., Sahajpal, N. S., Omar, N., Ananth, S., Ahluwalia, P. K., Farmaha, J., Woodall, J., & Kolhe, R. (2026). Comprehensive Genomic Profiling for Precision Oncology: Analytical Validation and Clinical Utility in Solid Tumors. Diagnostics, 16(7), 1087. https://doi.org/10.3390/diagnostics16071087
Vancouver
Mondal AK, Vashisht A, Vashisht V, Sahajpal NS, Omar N, Ananth S, et al. Comprehensive Genomic Profiling for Precision Oncology: Analytical Validation and Clinical Utility in Solid Tumors. Diagnostics. 2026;16(7):1087. doi:10.3390/diagnostics16071087
BibTeX
@article{Mondal2026,
author = {Mondal, Ashis K and Vashisht, Ashutosh and Vashisht, Vishakha and Sahajpal, Nikhil S and Omar, Nivin and Ananth, Sudha and Ahluwalia, Pankaj Kumar and Farmaha, Jaspreet and Woodall, Jana and Kolhe, Ravindra},
title = {Comprehensive Genomic Profiling for Precision Oncology: Analytical Validation and Clinical Utility in Solid Tumors},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {7},
pages = {1087},
doi = {10.3390/diagnostics16071087}
}
EUVIMED